Yext, Inc.
For the period ended Oct 31, 2025. Filed Dec 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 8, 2025
YEXT$7.67+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
Condensed Consolidated Statements of Cash Flows
| Nine months ended October 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities: | ||
| Net income (loss) | $33,657 | $(20,673) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization expense | 20,304 | 12,101 |
| Impairment of long-lived assets | 3,807 | — |
| Bad debt expense | 2,033 | 1,017 |
| Stock-based compensation expense | 37,959 | 37,091 |
| Amortization of operating lease right-of-use assets | 7,063 | 6,471 |
| Adjustments to contingent consideration | (25,900) | 607 |
| Other, net | 663 | (751) |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions: | ||
| Accounts receivable | 49,817 | 55,285 |
| Prepaid expenses and other current assets | (1,822) | (74) |
| Costs to obtain revenue contracts | 9,249 | 10,476 |
| Other long term assets | 6,502 | 256 |
| Accounts payable, accrued expenses and other current liabilities | (17,480) | 7,181 |
| Unearned revenue | (77,384) | (89,117) |
| Operating lease liabilities | (10,604) | (8,312) |
| Other long term liabilities | (11,552) | 307 |
| Net cash provided by operating activities | 26,312 | 11,865 |
| Investing activities: | ||
| Capital expenditures | (1,650) | (1,769) |
| Cash paid in acquisitions, net of cash acquired | (18,801) | (89,407) |
| Net cash used in investing activities | (20,451) | (91,176) |
| Financing activities: | ||
| Proceeds from exercise of stock options | 1,773 | 1,137 |
| Proceeds from debt issuance | 99,000 | — |
| Repurchase of common stock | (59,776) | (6,760) |
| Payments for taxes related to net share settlement of stock-based compensation awards | (18,473) | (9,031) |
| Payments of deferred financing costs | (1,045) | (777) |
| Deferred acquisition payments | (13,509) | — |
| Proceeds, net from employee stock purchase plan withholdings | 2,099 | 2,218 |
| Net cash provided by (used in) financing activities | 10,069 | (13,213) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 4,347 | 345 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 20,277 | (92,179) |
| Cash, cash equivalents and restricted cash at beginning of period | 138,654 | 210,184 |
| Cash, cash equivalents and restricted cash at end of period | $158,931 | $118,005 |
Supplemental reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets:
| Nine months ended October 31, | ||
|---|---|---|
| (in thousands) | 2025 | 2024 |
| Cash and cash equivalents | $139,916 | $100,484 |
| Restricted cash, current and non-current | 19,015 | 17,521 |
| Total cash, cash equivalents and restricted cash | $158,931 | $118,005 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.